Doximity, Inc. (NASDAQ:DOCS) Shares Bought by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. grew its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 13.1% in the fourth quarter, HoldingsChannel reports. The fund owned 19,075 shares of the company’s stock after buying an additional 2,212 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Doximity were worth $1,018,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. FMR LLC increased its stake in shares of Doximity by 30.5% during the 3rd quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after acquiring an additional 1,598,602 shares during the last quarter. State Street Corp increased its stake in shares of Doximity by 2.5% during the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock valued at $160,947,000 after acquiring an additional 88,922 shares during the last quarter. Geode Capital Management LLC increased its position in Doximity by 19.8% during the 3rd quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after purchasing an additional 472,565 shares in the last quarter. Los Angeles Capital Management LLC increased its position in Doximity by 33.7% during the 4th quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company’s stock worth $46,466,000 after purchasing an additional 219,448 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Doximity by 4.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 753,001 shares of the company’s stock worth $32,808,000 after purchasing an additional 31,966 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Buying and Selling

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 37.40% of the stock is currently owned by company insiders.

Doximity Price Performance

Shares of DOCS opened at $67.78 on Wednesday. The business’s fifty day moving average price is $62.30 and its 200 day moving average price is $51.18. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21. The stock has a market capitalization of $12.65 billion, a PE ratio of 67.78, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39.

Analyst Ratings Changes

DOCS has been the subject of a number of research analyst reports. Needham & Company LLC increased their target price on shares of Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Truist Financial increased their price objective on shares of Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research report on Thursday, November 14th. Leerink Partnrs raised shares of Doximity from a “hold” rating to a “strong-buy” rating in a research report on Friday, February 7th. Raymond James reaffirmed an “outperform” rating and issued a $83.00 price objective (up previously from $65.00) on shares of Doximity in a research report on Friday, February 7th. Finally, Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and increased their price objective for the company from $40.00 to $60.00 in a research report on Wednesday, November 13th. Eleven investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.